Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Signal transduction pathway of the BCR-ABL fusion gene and Imatinib... | Download Scientific Diagram
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
BCR-ABL signalling pathways. | Open-i
Pharmaceutics | Free Full-Text | BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
BCR/ABL inhibition by an escort/phosphatase fusion protein | PNAS
NEJM -- Chronic Myeloid Leukemia -- Advances in Biology and New Approaches to Treatment -- Figure 3
Bcr-Abl阻害 | Bcr-Abl Inhibition
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase* - Journal of Biological Chemistry
Figure 1 | The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells